Venetoclax or placebo in combination with bortezomib and dexamethasone in relapsed or refractory multiple myeloma (BELLINI): final overall survival results from a randomised, phase 3 study
Titel:
Venetoclax or placebo in combination with bortezomib and dexamethasone in relapsed or refractory multiple myeloma (BELLINI): final overall survival results from a randomised, phase 3 study
Auteur:
Kumar, Shaji K Harrison, Simon J Cavo, Michele de la Rubia, Javier Popat, Rakesh Gasparetto, Cristina Hungria, Vania Salwender, Hans Suzuki, Kenshi Kim, Inho Onishi, Maika Ku, Grace Pothacamury, Rajvineeth Jalaluddin, Muhammad Zeng, Jiewei Ross, Jeremy A Dobkowska, Edyta Moreau, Philippe